Novartis highlights transformative oncology research with 65+ abstracts at ASH and SABCS 2024
Novartis will present data from more than 65 abstracts, including investigator-initiated trials at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition and the 2024 San… read more.